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Abstract  33 
Developing repair strategies for osteochondral tissue presents complex challenges due to its 34 
interfacial nature and complex zonal structure, consisting of subchondral bone, intermediate 35 
calcified cartilage and the superficial cartilage regions. In this study, the long term ability of a 36 
multi-layered biomimetic collagen-based scaffold to repair osteochondral defects is 37 
investigated in a large animal model: namely critical sized lateral trochlear ridge and medial 38 
femoral condyle defects in the caprine stifle joint. The study thus presents the first data in a 39 
clinically applicable large animal model. Scaffold fixation and early integration was 40 
demonstrated at 2 weeks post implantation. Macroscopic analysis demonstrated improved 41 
healing in the multi-layered scaffold group compared to empty defects and a market 42 
approved synthetic polymer osteochondral scaffold groups at 6 and 12 months post 43 
implantation. Radiological analysis demonstrated superior subchondral bone formation in 44 
both defect sites in the multi-layered scaffold group as early as 3 months, with complete 45 
regeneration of subchondral bone by 12 months. Histological analysis confirmed the 46 
formation of well-structured subchondral trabecular bone and hyaline-like cartilage tissue in 47 
the multi-layered scaffold group by 12 months with restoration of the anatomical tidemark. 48 
Demonstration of improved healing following treatment with this natural polymer scaffold, 49 
through the recruitment of host cells with no requirement for pre-culture, shows the 50 
potential of this device for the treatment of patients presenting with osteochondal lesions. 51 
 52 
1 Introduction 53 
Osteochondral defects, resulting from traumatic injury or disease, are problematic within the 54 
clinical setting due to their limited potential for repair. A particular challenge presents due to 55 
the poor healing potential and avascular nature of cartilage and the interfacial nature of 56 
osteochondral tissue, with its complex zonal structure consisting of subchondral bone, 57 
intermediate calcified cartilage and the superficial cartilage regions (Matsiko et al, 2013). In 58 
the development of biomaterial and tissue engineering strategies for repairing this complex 59 
system, compositional, structural and mechanical factors all require consideration. While 60 
there have been recent advances in cell-based strategies and drug, gene and growth factor 61 
delivery systems for cartilage repair, these approaches are still limited by cost and the 62 
significant regulatory hurdles associated with clinical translation (Madry et al., 2014; Lee et 63 
al., 2013). Thus the development of effective cell-free biomaterial-based approaches remains 64 
a critically important goal within the field of tissue engineering. The ideal biomaterial solution 65 
would achieve repair by encouraging the recruitment of cells from the underlying bone 66 
marrow and providing the physical and biochemical cues to direct these cells to regenerate 67 
the different regions of the joint.  68 
 69 
Early attempts at the design of materials for the treatment of osteochondral defects focussed 70 
on the development of separate biomaterials for repair of the cartilage and bone regions 71 
which were fused together to create a bi-layered biomaterial. However, limited success has 72 
been achieved to date with this type of approach (Niederauer et al. 2000; O’Shea et al., 2008). 73 
In particular it is recognised that the calcified cartilage layer plays a significant role in 74 
preventing vascularisation of the overlying cartilage. The absence of this vital layer can result 75 
in bony ingrowth into the cartilage region (Hunziker et al. 2002). While a range of synthetic 76 
materials, including polycaprolactone (PCL) poly L-lactic acid (PLLA) and polyglycolic acid 77 
(PGA), have been used in cartilage repair applications with some success, natural biomaterials 78 
have a number of recognised advantages and thus may present an improved approach 79 
(Matsiko et al. 2013). In particular, collagen, which is present in most biological tissues, 80 
exhibits well documented biocompatibility and offers a number of advantages for use in 81 
tissue repair including ease of resorption in vivo without any resultant adverse response, 82 
greater cellular interaction due to the presence of ligands which may facilitate cell adhesion, 83 
and it can be co-polymerized with other biological materials to improve their bio-84 
functionality. For example, collagen has been successfully combined with hydroxyapatite and 85 
chondroitin sulphate for bone repair and hyaluronic acid for cartilage repair (Tampieri et al. 86 
2008; Zhou et al. 2011; Matsiko et al. 2012; Murphy et al. 2010; Farrell et al. 2006; Tierney & 87 
O’Brien 2009; Gleeson et al. 2010). Following this rationale, and based on the extensive 88 
experience with collagen-based biomaterials within our group, a multi-layered collagen-89 
based scaffold with distinct but seamlessly integrated layers, that mimic the structure and 90 
composition of osteochondral tissue, has been developed (Levingstone et al. 2014; Gleeson 91 
et al. 2009). This scaffold is designed specifically for osteochondral defect repair and is 92 
fabricated using a novel ‘iterative layering’ freeze-drying technique to produce its seamlessly 93 
integrated layered structure (Fig. 1a). It consists of a bone layer composed of collagen type I 94 
and hydroxyapatite (HA) exhibiting osteoinductive properties and potential for bone repair 95 
(Gleeson et al. 2010; Murphy et al. 2014; Lyons et al. 2014; David et al., 2015), a type I collagen 96 
and hyaluronic acid (HyA) intermediate layer representing the calcified cartilage region of 97 
native tissue, and a type I, type II collagen and HyA composite cartilaginous layer with 98 
excellent chondrogenic properties (Matsiko et al. 2012). Clinically, the scaffold is designed as 99 
an off-the-shelf cell-free biomaterial for press-fit implantation into an osteochondral defect 100 
site which, upon implantation into an osteochondral defect, enables infiltration of blood and 101 
cells from the host bone marrow through the seamlessly integrated multi-layered porous 102 
structure. The incorporated extracellular matrix macromolecules combined with biostructural 103 
and biomechanical properties are designed to encourage the proliferation and direct the 104 
differentiation of MSCs to produce bone, calcified cartilage and cartilage within the requisite 105 
regions. The regenerative potential of this multi-layered scaffold has been demonstrated in 106 
vitro (Levingstone et al., 2014) and this study presents the first data in a clinically applicable 107 
large animal model. 108 
 109 
For clinical translation, in vivo assessment in a large animal model is required in order to truly 110 
evaluate the regenerative potential of any therapy which aims to eventually treat humans. 111 
The goat (caprine) stifle joint model presents an ideal model for cartilage repair as it closely 112 
matches the joint mechanics in the human situation (Patil et al. 2014). Additionally, the 113 
proportion of cartilage to subchondral bone and the subchondral bone consistency in goats 114 
is similar to humans (Ahern, 2009; Proffen et al. 2012). Identification of a suitable time scale 115 
for assessment also presents a challenge when developing materials for articular cartilage 116 
repair. In many cases, early repair with fibrous or fibro-cartilage repair tissue can appear 117 
promising, however, such tissue is mechanically unstable with degeneration likely over time 118 
(Falah et al. 2010) and thus evaluation at later points of up to 12 months post-implantation is 119 
ideally required (ASTM, 2010).   120 
 121 
The objective of this study was thus to assess the ability of this novel multi-layered collagen-122 
based scaffold to regenerate and repair osteochondral tissue in two surgically created critical 123 
sized osteochondral defects within the caprine stifle joint - the partial load bearing lateral 124 
trochlear ridge and the full load bearing medial femoral condyle - and to compare the in vivo 125 
response to that seen in an empty defect negative control and a market approved bi-layered 126 
synthetic polymer scaffold. The specific aims were firstly to assess scaffold fixation, cellular 127 
infiltration and early tissue responses to the multi-layered scaffold at 2 weeks post 128 
implantation. Following on from this matrix deposition within the defect site was evaluated 129 
over time points of 3, 6 and 12 months to investigate if the biochemical and biostructural 130 
properties of this multi-layered scaffold enable regeneration of superficial articular cartilage, 131 
intermediate calcified cartilage and deep subchondral bone, with a zonal architecture similar 132 
to that of native osteochondral tissue. 133 
 134 
2 Materials and methods 135 
2.1 Fabrication of multi-layered scaffolds 136 
Multi-layered scaffolds were fabricated using a unique iterative layering fabrication method 137 
developed in our lab (Levingstone et al. 2014) (Fig. 1a). Briefly, this process involved 138 
fabrication of an initial bone layer by blending type I collagen (Col1) [0.5% (w/v), Collagen 139 
Matrix Inc., NJ, USA] with hydroxyapatite (HA) [1% (w/v) Plasma Biotal, UK] at 4˚C for 4 hours 140 
to produce a Col1HA slurry, prior to freeze-drying in a stainless steel tray (60 mm x 60 mm 141 
internal diameter) at a freezing rate of 1 ˚/min to a final freezing temperature of -40˚C 142 
(Gleeson et al. 2010). Following freeze-drying the scaffold was cross-linked using 1-ethyl-3-143 
(3-dimethylaminopropyl) carbodiimide (EDAC)/N-hydroxysuccinimide (NHS) (Sigma–Aldrich, 144 
Arklow, Ireland) at a concentration of 6 mM EDAC g-1 of collagen, and a 5:2 M ratio of 145 
EDAC:NHS for 2 hours at room temperature (Haugh et al. 2011). The intermediate layer slurry, 146 
consisting of Col1 [0.5% (w/v)], and hyaluronic acid sodium salt derived from streptococcus 147 
equi. (HyA) [0.05% (w/v), Sigma–Aldrich, Arklow, Ireland] was then added on top of the 148 
hydrated bone layer scaffold with freeze-drying repeated as before. Finally, the cartilage layer 149 
slurry, consisting of Col1 [0.25% (w/v)], type II collagen (Col2) [0.25% (w/v) porcine type 2 150 
collagen, Biom’up, Lyon, France] and HyA [0.05% (w/v], was added and the process of freeze-151 
drying was repeated again as described previously, incorporating prolonged freezing and 152 
drying steps to ensure optimal freeze-drying of the multi-layered construct. Following freeze-153 
drying, the scaffolds were dehydrothermally (DHT) cross-linked in a vacuum oven (VacuCell, 154 
MMM, Germany) at 105°C and a pressure of 50 mTorr for 24 hours to generate cross-links 155 
through a condensation reaction and also sterilise the multi-layered scaffold sheet. Cylindrical 156 
scaffold plugs were cut to a diameter of 7 mm and a depth of 6 mm in order to provide a 157 
secure press-fit on implantation. Finally, the plugs were EDAC cross-linked again under sterile 158 
conditions as described previously. 159 
 160 
2.2 Study design 161 
In vivo assessment was carried out in a bi-lateral goat stifle joint model under ethical approval 162 
(University College Dublin - AREC-P-11-31) and an animal licence granted by the Irish 163 
Government Department of Health (B100/4317). A total of 19 adult female goats (2-3 years 164 
old) were divided into 4 groups for assessment: 2 week and 3, 6 and 12 month post-165 
implantation with n numbers based on power analysis to provide an n=7 for the multi-layered 166 
scaffold group as per Table 1. Surgeries and analysis for 2 week time points were carried out 167 
first to assess surgical approach, scaffold fixation and early in vivo response. Following 168 
positive findings at this early time point, the remaining 3, 6 and 12 month surgeries were 169 
carried out. Surgeries were carried out bi-laterally with two defect sites created per stifle 170 
joint, one on the lateral trochlear ridge and one on the medial femoral condyle (Fig. 1b and 171 
c), with both sites within the same joint receiving the same treatment as per the treatment 172 
plan set out in Table 1. 173 
 174 
2.3 Surgical procedure and scaffold implantation in caprine stifles 175 
The goats were sedated using Diazepam (0.3-0.4 mg/kg IV) and Butorphanol (0.2 mg/kg IV). 176 
An epidural was administered using morphine (0.2 mg/kg) together with Bupivicaine (0.25-177 
0.35mg/kg). Following placement of an intravenous catheter, anaesthesia was induced with 178 
propofol to effect (max dose 4mg/kg IV). Anaesthesia was maintained on isoflurane with 179 
ventilation to maintain normal end tidal CO2 between 4.6 and 6kPa. Isotonic fluids were 180 
provided at 10ml/kg/hr. The goats were placed in dorsal recumbency and an arthrotomy of 181 
each stifle joint was then performed using the lateral para-patellar approach. Two critical 182 
sized defects (Jackson et al., 2001), 6 mm in diameter x 6 mm in depth, were created per stifle 183 
joint, and one on the lateral trochlear ridge and one on the medial femoral condyle. Drilling 184 
was performed using a hand drill to minimise heat production, with a 6 mm pointed drill bit 185 
followed by a custom 6 mm flattened drill bit and drill sleeve to provide a uniform defect with 186 
flattened bottom and controlled depth. The joint was flushed with normal saline and the stifle 187 
joints were assigned to one of the three treatment groups: 1) empty defect, 2) multi-layered 188 
scaffold, 3) bi-layered synthetic polymer scaffold (Trufit, Smith & Nephew, MA, USA). Both 189 
scaffold types were “press-fit” into the defect sites. The synthetic polymer scaffold was press-190 
fit in place in accordance with the manufacturers’ guidelines. Routine closure of the joint 191 
capsule, subcutaneous tissues and skin was then carried out. Morphine (0.1 – 0.2 mg/kg IM) 192 
and non-steroidal anti-inflammatory drugs (NSAIDs) [Carprofen (1.5 - 2.5 mg/kg 193 
subcutaneously) (Rimadyl), Zoetis, New Jersey, USA] were administered at the end of 194 
anaesthesia. 195 
 196 
Following surgery, goats were housed in small indoor pens to allow skin incisions to heal and 197 
were allowed full weight bearing. During this period the animals were closely monitored to 198 
ensure adequate analgesia. NSAIDs and antibiotics [Amoxicillin (Noroclav), Norbook 199 
Laboratories Ltd; Corby, UK] were administered for 5 days post-surgery. Two weeks post-200 
operatively, following removal of sutures, animals were let out to pasture for the remainder 201 
of the study period. Euthanasia was carried out at the 2 week and 3, 6 and 12 month time 202 
points with an overdose of sodium pentobarbital and stifle joints were harvested. 203 
 204 
2.4 Macroscopic assessment of the level of repair at defect sites 205 
Post euthanasia, the joints were opened and the defect site and surrounding joint tissues 206 
were examined. Synovial fluid was aspirated and inspected. Photographs of the defect sites 207 
were taken and three independent assessors who were blinded to the treatment groups 208 
assessed the quality of repair and regeneration using a macroscopic evaluation tool (Getgood 209 
et al. 2012) (Table 2). Osteochondral segments containing the defect sites surrounding by a 210 
margin of approximately 5 mm were subsequently resected and fixed in 10% formalin prior 211 
to further analysis. 212 
 213 
2.5 Micro-computed tomography evaluation of subchondral bone formation 214 
Micro-computed tomography (micro-CT) analysis was performed on all samples using a 215 
Scanco Medical 40 Micro-CT (Bassersdorf, Switzerland) with 70 kVP X-ray source and 112 μA 216 
(resolution of ~36 µm) in order to assess the quantity and structure of the new bone formed 217 
within the defect site. A constrained Gaussian filter was applied to partly suppress noise (filter 218 
width (0.8) and filter support (1)). Three-dimensional reconstructions were performed using 219 
the Image-J and Bone-J software (public domain software developed by Wayne Rasband in 220 
the National Institute of Health, Maryland, USA) (Schneider et al. 2012) and a volume of 221 
interest (VOI) was defined within the subchondral bone region of the defect site. Subchondral 222 
bone repair was expressed as percentage bone volume over the total volume (% BV/TV). 223 
 224 
2.6 Histological assessment of the level of repair at defect sites  225 
Specimens were decalcified using 15% ethylenediaminetetraacetic acid (pH of 7.4) (EDTA, 226 
Fluka BioChemika, Sigma-Aldrich, Arklow, Ireland), then processed using an automated tissue 227 
processor (ASP300, Leica, Germany) before being embedded in paraffin wax blocks. 228 
Subsequently, 10 µm sections were then cut using a rotary microtome (Microsystems GmbH, 229 
Germany), and mounted on L-polylysine coated glass slides (Thermo Scientific, MenzelGmnh 230 
& Co KG, Germany). Following dewaxing, sections were stained histologically following 231 
standard protocols in order to assess, the quantity and quality of repair tissue and integration 232 
with native tissue. Specifically, haematoxylin and eosin (H&E) was used to assess cell 233 
arrangement and morphology and tissue formation and integration; Masson’s trichrome was 234 
used to assess the collagen formation within the cartilage region and bone formation with 235 
the subchondral bone region; and safranin-O with fast green counterstain was used to assess 236 
the presence of glycosaminoglycan within the repair tissue in the cartilage region. Images 237 
from each specimen were acquired using bright-field microscopy and digitised (Nikon 238 
Microscope Eclipse 90i with NIS Elements software v3.06, Nikon Instruments Europe, The 239 
Netherlands). The thickness of the cartilage layer (measured from the joint surface to the 240 
tidemark) in the trochlear ridge (n=3) and medial condyle (n=3) defect sites was compared to 241 
normal cartilage thickness adjacent to the defect area. Qualitative histological scoring was 242 
carried out independently by a certified histopathologist under blinded conditions using a 243 
modification of the  histological scoring system developed by O’Driscoll (O’Driscoll et al. 1986) 244 
which has been previously validated for the assessment of articular cartilage repair (Rutget et 245 
al. 2010; Moojen et al. 2002) while also allowing assessment of the subchondral bone. The 246 
scoring system was used to provide a comprehensive evaluation of repair within the 247 
osteochondral defect site using six categories (I) the nature of cartilage repair tissue (II) 248 
structural characteristics, (III) freedom from cellular changes or degradation, (IV) freedom 249 
from degradation changes in articular cartilage (V) reconstitution of subchondral bone and 250 
(VI) safranin-O staining, and has a maximum possible score of 28 (Table 3).  251 
 252 
2.7 Statistical analysis 253 
Data from the in vivo experiments were analysed with two-way ANOVA and Bonferroni post 254 
hoc analysis for multiple comparisons to look for any statistical differences among the three 255 
groups with an alpha value set at p<0.05. Data was analysed using GraphPad Prism version 256 
5.00 for Windows (GraphPad Software, San Diego California USA). 257 
 258 
3 Results 259 
3.1 Clinical observations after scaffold implantation 260 
During surgery, scaffolds were successfully implanted using the press-fit implantation 261 
technique and were seen to fill with blood on implantation (Fig. 2a). All animals recovered 262 
well post operatively and within 5 days ambulated freely with no signs of distress or limping 263 
for the duration of the study. There were no post-operative complications up to the 12 month 264 
time point.  265 
 266 
3.2 Macroscopic assessment of defect repair  267 
On opening of the joints, gross macroscopic visual evaluation of the repair tissue was carried 268 
out. Synovial fluid was found to be straw coloured, clear and normal in all cases. There was 269 
no evidence of negative inflammatory responses or degenerative changes, construct 270 
delamination or migration into the joint cavity in the treated joints based on visual 271 
assessment at the time of retrieval. At 2 weeks post implantation, macroscopic assessment 272 
enabled visualisation of the scaffold within the defect site and demonstrated successful 273 
fixation of the scaffold using the press-fit implantation method (Fig. 2b and c).  At 3 months, 274 
some level of defect fill was observed in both defect sites in the empty and multi-layered 275 
scaffold groups, with signs of repair tissue present within the defect site. By 6 months, both 276 
defect sites in the multi-layered scaffold group showed evidence of smooth cartilage-like 277 
tissue with good integration of the repair tissue to the surrounding healthy tissue within the 278 
defect site, whereas incomplete defect fill and limited tissue integration was observed in the 279 
synthetic polymer scaffold group. At 12 months, the defect sites in the multi-layered scaffold 280 
group showed improved articular cartilage regeneration and repair compared to empty or the 281 
synthetic polymer scaffold groups (Fig. 3a and c). In this group, cartilage was hyaline-like in 282 
appearance, with complete integration of the newly formed cartilage into the surrounding 283 
healthy tissue. Additionally, there was complete defect fill, and the colour of the cartilage 284 
within the defects was close to that of the surrounding native tissue. In contrast, in the empty 285 
defect and the synthetic polymer scaffold groups defect sites displayed signs of incomplete 286 
healing. Notably, in the medial condyle treated with the synthetic polymer scaffold there was 287 
fibrous-like tissue present within the defect and the presence of large fissures with the repair 288 
tissue was observed. Noticeable depressions were observed in the central region of the defect 289 
site in the empty defect group.  290 
 291 
Gross morphological scores were consistent with findings of the visual evaluation (Fig. 3b and 292 
d). At 3 months, there was no statistically significant difference between scores for the empty 293 
defect group in the trochlear ridge and medial condyle defect sites compared to the multi-294 
layered scaffold group. At 6 months, the empty defect trochlear ridge group displayed 295 
significantly higher scores when compared to multi-layered (p<0.01) and the synthetic 296 
polymer scaffold (p<0.001). However, higher scores were seen in the multi-layered scaffold 297 
in the medial condyle defect sites compared to empty and the synthetic polymer scaffold 298 
groups; with significance found between the multi-layered scaffold group and the synthetic 299 
polymer scaffold group (p<0.01). At the final 12 month evaluation, the trochlear ridge defect 300 
site in the multi-layered scaffold group showed greater levels of repair compared to empty 301 
(p<0.05) and the synthetic polymer scaffold (p<0.01) groups (Fig. 3b). A similar trend was 302 
observed in the medial condyle with the multi-layered scaffold group demonstrating 303 
significantly higher gross morphological scores compared to empty (p<0.001) and the 304 
synthetic polymer scaffold group (p<0.01) (Fig. 3d). Overall, these results indicate that the 305 
gross morphological appearance was deemed to be superior by three independent assessors 306 
in both defect sites in the multi-layered group compared to the empty and synthetic polymer 307 
scaffold groups at the final 12 month time point.  308 
 309 
3.3 Micro-computed tomography evaluation of subchondral bone formation 310 
Following visual assessment of repair tissue, levels of subchondral bone formation were 311 
investigated using micro-CT. Analysis of 2D projections demonstrated superior levels of 312 
subchondral bone formation in both defect sites in the multi-layered scaffold group starting 313 
as early as 3 months, with improved levels of subchondral bone repair at 6 months and 314 
complete regeneration of subchondral bone by 12 months (Fig. 4a and c). In contrast, the 315 
empty group medial condyle and trochlear ridge defect sites showed minimal signs of healing 316 
at the 3 and 6 month time points, with some subchondral bone repair observed by 12 months 317 
post-op. In the synthetic polymer scaffold group, while there was some variability, as early as 318 
6 months, there was evidence of osteolysis resulting in defect widening in both defect sites 319 
in the synthetic polymer scaffold group. As a consequence of the osteolysis, in some cases 320 
the synthetic polymer scaffold groups presented with cavities that persisted up to 12 months 321 
and displayed minimal signs of subchondral bone formation. These findings were confirmed 322 
through quantification of the bone volume within the defect site with significantly higher 323 
BV/TV values in the multi-layered scaffold group trochlear ridge and medial condyle defect 324 
sites relative to the empty and the synthetic polymer scaffold groups at 6 months (p<0.001) 325 
and 12 months (trochlear ridge (p<0.001) and  medial condyle (p<0.05). 326 
 327 
3.4 Microscopic assessment of repair within defect sites 328 
Histological assessment of repair supported the macroscopic and micro-CT findings with 329 
defect repair occurring in the multi-layered scaffold group over the 3, 6 and 12 month time 330 
points. The multi-layered scaffold group displayed evidence of newly formed repair tissue 331 
which integrated into the surrounding healthy cartilage by 12 months in both defect sites as 332 
evidenced by the haematoxylin and eosin (H&E) staining (Fig. 5a and b) and hyaline-like 333 
cartilage formation as demonstrated by safranin-O staining (Fig. 6a and b). The structure of 334 
the cartilage repair tissue in the multi-layered group had an immature fibrous appearance at 335 
6 months but by 12 months showed strong sulphated GAG staining and a more hyaline-like 336 
appearance (Fig. 7a and b). Cells within the cartilage region displayed a rounded morphology 337 
and were found residing within lacunae and with alignment typical of native cartilage (Fig. 7a 338 
and 7b). The newly formed hyaline-like cartilage tissue was supported by a well-structured 339 
subchondral trabecular bone that was hard to distinguish from the surrounding healthy bone. 340 
Most notably, tidemark formation was observed with no evidence of any bony invasion past 341 
the calcified cartilage layer into the regenerated cartilage layer (Fig. 7c). In comparison, the 342 
trochlear ridge and medial condyle defects treated with the synthetic polymer scaffold 343 
showed loss of subchondral bone with resorption of surrounding healthy osseous tissue at 6 344 
and 12 months post op. There was evidence of cavity formation in the subchondral bone, 345 
causing the overlying cartilage-like tissue to subside into the defect. The nature of the 346 
cartilage tissue was predominantly fibrocartilage with varying amounts of primarily woven 347 
bone and fibrous connective tissue. Furthermore, remnants of the scaffolds were still visible 348 
at 6 and 12 months (Fig. 7d, e and f), and there was a complete failure of integration of the 349 
scaffold with the surrounding healthy tissue. At 12 months, in the empty group, the trochlear 350 
ridge and medial condyle defects were filled with poor quality fibrous tissue with poor 351 
regeneration of the individual cartilage, calcified cartilage and bone layers of the 352 
osteochondral defect.   353 
 354 
Regeneration of cartilage and bone tissue in the osteochondral defect was quantified using a 355 
histological evaluation tool based on the O’Driscoll scoring system to allow assessment of the 356 
articular cartilage and also the subchondral bone (Rutget et al. 2010; Moojen et al. 2002; 357 
Getgood et al. 2012). As early as 3 months, the multi-layered scaffold group performed better 358 
with higher histological scores compared to the empty group; although this was only 359 
significant in the medial condyle defects. At 6 months, the histological scores for the trochlear 360 
ridge and medial condyle defects were comparable between all treatment groups. However, 361 
and perhaps most importantly, at 12 months, both the trochlear ridge and medial condyle 362 
defect sites treated with the multi-layered scaffold demonstrated improved repair as 363 
evidenced by higher histological scores compared to the empty and synthetic polymer 364 
scaffold groups (p<0.05) (Fig. 8a and b). Additionally, at this time point the nature of the tissue 365 
above the tidemark in the multi-layered group was predominantly hyaline as evidenced by 366 
positive safranin-O staining. Over the 12 months study period, there was evidence of the 367 
maturation of the cartilaginous tissue in the multi-layered scaffold group compared to the 368 
empty and synthetic polymer scaffold groups. In addition, there was demonstrated 369 
integration with the surrounding healthy cartilage tissue and reconstitution of subchondral 370 
bone without any signs of bone overgrowth beyond the tidemark were demonstrated. 371 
Consequently, the multi-layered group achieved significantly better histological scores 372 
(p<0.05) compared to the empty and synthetic polymer scaffold groups.  373 
 374 
3.5 Microscopic assessment of cartilage thickness at defect sites  375 
The findings of the histological evaluation were reflected in the cartilage thickness analysis 376 
where the multi-layered scaffold group showed greater cartilage thickness compared to the 377 
empty (p<0.01) and the synthetic polymer scaffold groups (p<0.05) at 6 months and 12 378 
months respectively (Fig. 8c). The cartilage thickness at 3 months was difficult to measure due 379 
to lack of a clearly visible tidemark layer in the defects, therefore only 6 and 12 month 380 
measurements were taken with both medial condyle and trochlear ridge sites being analysed 381 
together. At 6 months, the multi-layered group demonstrated greater cartilage thickness (213 382 
µm); this was significant compared to empty (96 µm, p<0.01) and the synthetic polymer 383 
scaffold (140 µm, p<0.05) groups. At 12 months, an increase in cartilage thickness values were 384 
seen in the multi-layered group (238 µm) compared to empty (98 µm, p<0.01) and the 385 
synthetic polymer scaffold (66 µm p<0.05) groups. Although thickness values appeared lower 386 
than normal cartilage thickness (256 µm), this was not significant at either time point. Most 387 
notably, the cartilage thickness in the synthetic polymer scaffold group displayed a reduction 388 
from 6 months to 12 months compared to the defects treated with the multi-layered scaffold. 389 
 390 
4 Discussion 391 
This study demonstrates the significant clinical potential of this multi-layered scaffold as an 392 
off-the-shelf biomaterial solution for osteochondral defect repair and demonstrates the 393 
potential for a positive impact in the treatment of patients presenting with osteochondal 394 
lesions. The development of advanced biomaterial-based strategies for osteochondral defect 395 
repair is of critical importance in clinical orthopaedics in order to address a major clinical 396 
need. To address this, a novel multi-layered collagen-based osteochondral defect repair 397 
scaffold, consisting of three distinct but seamlessly integrated layers designed to mimic the 398 
stratified composition of native osteochondral tissue, has been developed within our lab 399 
(Levingstone et al. 2014). The objectives of this study were therefore to evaluate the ability 400 
of this novel multi-layered scaffold to regenerate and repair osteochondral tissue within two 401 
surgically created critical sized osteochondral defects in the caprine stifle joint, the medial 402 
femoral condyle and lateral trochlear ridge, and to compare the in vivo response to that seen 403 
in an empty defect at 3, 6 and 12 month time points and market approved synthetic polymer 404 
scaffold at 6 and 12 months. Scaffold fixation and early integration was demonstrated at 2 405 
weeks post implantation. Macroscopic analysis demonstrated improved healing in the multi-406 
layered scaffold group compared to empty defects and a market approved synthetic polymer 407 
osteochondral scaffold groups at 6 and 12 months post implantation. Radiological analysis 408 
demonstrated superior subchondral bone formation in both defect sites in the multi-layered 409 
scaffold group as early as 3 months, with complete regeneration of subchondral bone by 12 410 
months. Histological analysis confirmed the formation of well-structured subchondral 411 
trabecular bone and hyaline-like cartilage tissue in the multi-layered scaffold group by 12 412 
months with restoration of the anatomical tidemark.  413 
 414 
 415 
A significant outcome for this study was that there were no joint related adverse events or 416 
post-operative complications with all animals recovering well. This demonstrates the safety 417 
of the multi-layered scaffold and further validates the surgical approach used. While 418 
promising in vitro results have already been demonstrated, assessment in large animals is 419 
desirable in order to truly evaluate the regenerative capacity of this scaffold. While numerous 420 
large animal models are used in the literature, the caprine stifle joint defect model is widely 421 
accepted as an ideal large animal model for assessment of the efficacy of strategies for 422 
cartilage repair, due to the thickness of the cartilage present on the articulating surfaces and 423 
also the anatomical similarity of the stifle joint to human knee joint (Ahern et al. 2009; Proffen 424 
et al. 2012). The use of two defect sites within the stifle joint provides the opportunity to 425 
assess tissue regeneration in two different loading environments, the partially loaded 426 
trochlear ridge and fully loaded femoral condyle. Comparison of joint forces has 427 
demonstrated that peak contact pressures in goat knees are comparable to those generated 428 
in human knees (Patil, 2014). The goat model also allows similar surgical techniques to those 429 
used in humans. The 6 mm x 6 mm size defect used was also validated with minimal tissue 430 
regeneration observed in the empty defect groups, in line with findings from previous studies 431 
(Jackson et al. 2001). Infiltration of blood and cells into the empty defect from the 432 
subchondral bone led to fibrous tissue formation at early time points and good early 433 
macroscopic scores, however, it is evident from radiological and histological assessment that 434 
this does not translate to repair of the cartilage and subchondral bone at later time points. 435 
Jackson et al. (2001) reported widening of the defect walls in an empty defect created in the 436 
medial femoral condyle of a goat knee joint by 6 weeks post op, resorption of the bone 437 
surrounding the defect by 26 weeks and sclerotic bone at the defect edges by 52 week post 438 
op. Similar findings were observed in this study and thus it is clear that without intervention, 439 
complete healing of the osteochondral defect site cannot be achieved.  440 
 441 
There are two defect sites commonly used in the literature, the lateral trochlear ridge and 442 
medial femoral condyle (Niederauer et al. 2000; Orth et al. 2013). Levels of repair are reported 443 
to vary between the two defect sites and the ideal site for assessment of the efficacy of 444 
materials for cartilage repair is still not clear. Orth et al. (2013) reported improved 445 
osteochondral repair in the trochlear ridge compared to the medial condyle at 6 months in 446 
an ovine model, whereas Niederauer et al. (2000) reported improved healing in the medial 447 
condyle compared to the trochlear at 6 months post implantation of an osteochondral defect 448 
repair scaffold. In this study a direct comparison between the tissue regeneration observed 449 
in the two sites was carried out. In the empty defect group, while BV/TV values were the same 450 
for both sites, macroscopic and histological scoring indicated that greater levels of 451 
spontaneous repair occurred in the trochlear ridge. In the multi-layered scaffold group 452 
macroscopic scoring and BV/TV values were marginally higher in the trochlear ridge defect 453 
site than the medial condyle, however, no statistical differences were found between the two 454 
sites. Thus while differences in loading and spontaneous repair exist between the two sites, 455 
when treated with the multi-layered scaffold similar levels of repair can be achieved.  456 
 457 
Retention of the scaffold within the defect site was demonstrated at 2 weeks post 458 
implantation, thus validating the press-fit fixation method without the use of a cast or splint 459 
mechanism to stabilise the joint. Several scaffold fixation strategies have been investigated in 460 
the literature, including gluing and suturing, but negative inflammatory responses (van 461 
Susante et al. 1999) and degradation changes due to suture trauma (Hunziker et al. 2008) 462 
have been reported. As the defect sites utilised in this model are both load-bearing, the 463 
scaffold would have been subjected to compressive forces during the study. Histological 464 
analysis at 2 weeks demonstrated that the scaffold has sufficient mechanical properties to 465 
remain within the defect site flush with the articular surface (Fig. 2d). It was also evident that 466 
the multi-layered porous architecture in the scaffold was maintained in the in vivo 467 
environment thus permitting cell infiltration into the scaffold structure. Upon implantation, a 468 
heterogeneous mixture of blood, immune, and precursor cells from the bone marrow enter 469 
into the defect site and infiltrate through the seamlessly integrated layers of the multi-layered 470 
scaffold. This was observed initially as a change in colour of the scaffold from white to red on 471 
implantation (Fig. 2a) and also demonstrated histologically (Fig. 2e, f and g). The results 472 
suggest that the infiltrating precursor cell population present is capable of differentiating to 473 
bone and cartilage forming cells, directed by the scaffold architecture and matrix 474 
macromolecules, resulting in repair of the surrounding tissues and, together with the immune 475 
cell population, remodelling and degradation of the implanted scaffold. This scaffold-476 
mediated approach offers advantages over complex cell seeded tissue engineering strategies 477 
as it negates the requirement for costly and time consuming ex vivo cell expansion and cell 478 
seeding procedures. 479 
 480 
Analysis of repair at the time points of 3, 6 and 12 months post-implantation demonstrated 481 
improved healing in the multi-layered scaffold group compared to the synthetic polymer 482 
scaffold or empty defect groups. Blinded macroscopic evaluation of repair tissue using a gross 483 
macroscopic scoring system indicated improved healing within the multi-layered scaffold 484 
group. While similar macroscopic scores were observed between the multi-layered scaffold 485 
and empty defect groups at 3 and 6 months, the multi-layered scaffold group exhibited 486 
improved healing over the synthetic polymer scaffold group at 6 months (Fig. 3b and d). 487 
Presence of a smooth white cartilaginous layer that appeared to be continuous with the 488 
surrounding healthy cartilage was observed in the trochlear ridge and medial condyle defect 489 
sites in the multi-layered scaffold group at 12 months with improved colour, and greater 490 
defect fill, integration and surface smoothness compared to the empty defect and synthetic 491 
polymer scaffold groups (Fig. 3a and c). Assessment of new bone formation using micro-CT 492 
demonstrated a clear trend showing superior levels of subchondral bone regeneration from 493 
3 months to 12 months post surgery in the multi-layered group defects compared to empty 494 
group and synthetic polymer scaffold (Fig. 4). In the multi-layered scaffold groups similar 495 
levels of bone repair were observed in both defect sites at both 6 and 12 month time points, 496 
with average BV/TV values of 0.56 in the trochlear ridge and 0.53 in the medial condyle at 12 497 
months. Comparison of the 2D micro-CT projections shows that early mineral deposition at 3 498 
and 6 months undergoes remodelling with advanced stages of bone repair evident in the 499 
multi-layered scaffold group at 12 months (Fig. 4a and c). While some new bone formation 500 
was observed in the empty defect group, repair remained incomplete up to 12 months post 501 
op. In the synthetic polymer scaffold group resorption of the osseous wall of the defect and 502 
defect widening was observed. Consequently, the synthetic polymer scaffold demonstrated 503 
lower bone volume (BV/TV) values compared to the multi-layered scaffold group. 504 
 505 
Histological analysis confirmed the findings from micro-CT showing reconstruction of 506 
subchondral bone plate forming the tidemark and repair of the underlying bone in the multi-507 
layered scaffold group with evidence of neovascularisation as early as 6 months (Fig. 5 and 6). 508 
Tidemark formation is essential in order to achieve long-term stability of the newly formed 509 
tissue; providing structural support to the overlying cartilaginous layer and also forming a 510 
natural boundary between vascularised subchondral bone and avascular articular cartilage to 511 
prevent bony overgrowth into the cartilaginous region of the defect site. Bony overgrowth 512 
has been linked with degenerative changes within the joint (Abarrategi et al. 2010) and is 513 
frequently observed following ACI procedures (Minas et al. 2005; Henderson et al. 2009) and 514 
resulting for other biomaterial approaches to osteochondral defect repair (Coburn et al. 515 
2012). Assessment of repair tissue in the cartilaginous region in the multi-layered scaffold 516 
group showed the presence of fibro-cartilage tissue at 6 months with more hyaline-like 517 
cartilage being observed by 12 months post op (Fig. 7a and b). At both time points cells 518 
displayed a rounded morphology and were found residing within lacunae, characteristics 519 
typical of chondrocytes in native cartilage, and showed cellular alignment typical of cartilage 520 
with matrix staining positive for glycosaminoglycans (Fig. 7a and b). Quantification of repair 521 
through histological scoring confirmed improved repair within the multi-layered scaffold 522 
group than the empty defect or synthetic polymer scaffold groups (Fig. 8a and b).  523 
 524 
Overall these results demonstrate that greater levels of repair resulted following treatment 525 
with the multi-layered scaffold than the synthetic polymer scaffold. Comparison of the 526 
composition and micro-structure of the scaffolds investigated here provides some 527 
explanation for the different responses observed in vivo. The multi-layered scaffold is 528 
composed of natural polymers, type I and type II collagen, hyaluronic acid (HyA) in addition 529 
to hydroxyapatite (HA). This has demonstrated significant potential in vitro to support 530 
chondrogenesis as well as in vivo healing by the collagen-HA bone layer (Gleeson et al. 2010; 531 
Lyons et al. 2014; Murphy et al. 2014; Matsiko et al. 2012). The main constituent of the 532 
synthetic polymer scaffold is polyglycolic acid (PLGA), and while this material has been shown 533 
to support cartilage production in vitro (Niederauer et al. 2000), its chondroinductive 534 
properties have not been demonstrated. The bone region of the multi-layered scaffold 535 
provides a more favourable biomimetic environment as the mineral phase present is 536 
hydroxyapatite which is found in native bone, whereas the synthetic polymer scaffold 537 
contains calcium-sulfate. Differences in scaffold degradation properties may also significantly 538 
contribute to the repair responses observed in each group. While the multi-layered scaffold 539 
had fully resorbed by the 6 month time point, remnants of the synthetic polymer scaffold 540 
persisted (Fig. 7d, e and f). Collagen-based materials degrade via natural enzymatic processes 541 
involving proteases such as collagenases, resulting in degradation products such as oligomeric 542 
peptide and saccharide fragments, that do not negatively affect their local microenvironment 543 
(Pek et al. 2004). In contrast, synthetic polymers have shown less favourable responses in vivo 544 
with previous reports highlighting negative inflammatory processes as a result of the 545 
degradation products of synthetic polymers (Sittinger et al. 1999; Asawa et al, 2012; Lee et al. 546 
2014). While a number of studies have reported clinical success using the synthetic polymer 547 
scaffold for osteochondral repair (Dhollander et al. 2012; Bekkers et al. 2013; Hindle et al. 548 
2014; Joshi et al., 2012; Pearce et al. 2012), some concerns have been raised over the long 549 
term efficacy of this device Carmont et al. (2009); Verhaegen J et al. (2015) and Getgood et 550 
al. (2012).  Polyglycolic acid (PLGA) degrades as a result of hydrolytic cleavage of ester bonds 551 
within the material leading to the release of acidic by-products including lactic acid and 552 
glycolic acid (Antheunis et al. 2010). Poor levels of tissue repair observed at 6 and 12 months 553 
within the synthetic polymer scaffold group can be attributed to this local acidic environment 554 
resulting from scaffold degradation. Similar findings have been reported previously by Asawa 555 
et al. (2012). Moreover, acid-sensitive bone structural components such as calcium 556 
phosphate may be weakened as a result, thus leading to the breakdown of bone tissue and 557 
the formation of bone cysts (Getgood et al. 2012). The recognised limitations of synthetic 558 
biomaterials for cartilage repair applications has led to a move to more natural materials, with 559 
recent osteochondral defect repair materials emerging onto the marketplace in Europe 560 
including Maioregen (Finceramica, Italy), a triphasic type I equine collagen osteochondral 561 
scaffold containing magnesium enriched hydroxyl appetite, and Agili C (Cartiheal, Israel) made 562 
from coralline aragonite.  563 
  564 
Taken together, the results presented here demonstrate the effectiveness of this multi-565 
layered collagen-based material in the treatment of focal osteochondral lesions and show an 566 
improved regenerative response following treatment with this collagen-based multi-layered 567 
scaffold in comparison to a market approved synthetic polymer scaffold. This study thus 568 
validates the use of this scaffold as an off-the-shelf cell-free therapeutic and demonstrates its 569 
potential for successful translation to the clinic. Due to its multi-layered structure, tailored 570 
compositional and biomechanical properties, this scaffold also provides an ideal platform for 571 
the development of advanced therapies for osteochondral defect repair and is ideally suited 572 
for the delivery of a range of complex biomolecules not limited to just cells but also for the 573 
delivery of growth factors or as gene-activated matrices to promote enhanced tissue repair. 574 
Such approaches have already been demonstrated with similar collagen-based scaffolds from 575 
our group (Castaño et al. 2015; Raftery et al. 2015; Quinlan et al. 2015; Tierney et al. 2013; 576 
Matsiko et al. 2015). While such advanced treatment systems still have a way to go before 577 
reaching the clinic, strategies such as these could thus lead to successful healing in the 578 
treatment of areas of large scale damage to the articular surface in the future.   579 
 580 
5 Conclusion 581 
Overall the results of this study have shown successful, in vivo repair and regeneration of the 582 
subchondral bone and overlying superficial cartilage with restoration of the tidemark within 583 
critical sized caprine osteochondral defects in 2 distinct joint locations, following implantation 584 
of a novel multi-layered collagen-based osteochondral defect repair scaffold. Evaluation of 585 
repair at 3, 6 and 12 months demonstrated that the biochemical and biostructural properties 586 
of this multi-layered scaffold enabled improved regeneration over a bi-layered synthetic 587 
polymer scaffold, with a zonal architecture similar to that of native osteochondral tissue 588 
observed in the multi-layered scaffold groups at 12 months. Results demonstrated greater 589 
levels of repair macroscopically, radiographically and microscopically, with quantification 590 
demonstrating increased cartilage thickness and superior levels of subchondral bone 591 
formation in the multi-layered scaffold group compared to empty and synthetic polymer 592 
scaffold groups. Taken together these results show the importance of biomaterial, 593 
biochemical and biostructural properties in the design of materials for tissue repair.  594 
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Figure 1: Multi-layered collagen-based scaffolds were implanted into defects in the goat stifle 837 
joint. a) The scaffold has a porous microstructure with distinct but seamlessly integrated layer 838 
designed specifically for the repair of bone, calcified cartilage and cartilage in an 839 
osteochondral defect. Critically sized defects, 6 mm x 6 mm, were created in b) the lateral 840 





Figure 2: a) On implantation the scaffolds were seen to fill with blood and cells from the bone 846 
marrow. Macroscopic assessment at 2 weeks showed that the scaffolds were present within 847 
the medial condyle (b) and trochelar ridge (c) defect sites. d) Histological assessment 848 
(Masson’s trichrome staining) showed cellular infiltration and early integration of repair 849 
tissue at 2 weeks post implantation in e) the cartilage layer, f) the intermediate layer and g) 850 




Figure 3: Gross morphology assessment of trochlear ridge (a,b) and medial condyle defects 855 
(c,d) at 3, 6 and 12 months. The defects treated with the multi-layered scaffold showed 856 
significantly higher gross morphology scores compared to the empty defects or the defects 857 
treated with the synthetic polymer scaffold. Representative macroscopic images show 858 
improved repair in the multi-layered scaffold group compared to the empty defect and 859 
synthetic polymer scaffold groups in b) the trochlear ridge and d) the medial condyle defect 860 
sites at 12 months. Statistical significant differences are represented as follows: * p < 0.05, ** 861 




Figure 4: Micro-CT analysis showed improved subchondral bone repair in the multi-layered 866 
scaffold group. 2D projection images show the failure of subchondral bone restoration in the 867 
empty defect and synthetic polymer scaffold groups in a) the trochlear ridge and b) the medial 868 
femoral condyle. In comparison, the multi-layered scaffold group showed enhanced repair of 869 
subchondral bone. Quantitative micro-CT analysis of regenerated bone within the defect 870 
space demonstrates significantly greater level of bone formation in the multi-layered scaffold 871 
group compared to the other groups at 6 and 12 months post op (b,d). The values are 872 
expressed as mean ± standard deviation. Statistical significant differences are represented as 873 




Figure 5: Histological staining (H&E) of the tissue repair in a) trochlear ridge and b) medial 878 
condyle at 3, 6 and 12 months post op. At 12 months, the empty group displays poor quality 879 
cartilage tissue and subchondral bone tissue, whereas the multi-layered scaffold group shows 880 






Figure 6: Histological staining (safranin-O) of a) the trochlear ridge and b) the medial condyle 887 
at 3, 6 and 12 months. The empty group and synthetic polymer scaffold groups display poor 888 
repair of cartilage and subchondral bone compared to the multi-layered scaffold group. Scale 889 




Figure 7: Histological analysis of repair tissue in the multi-layered scaffold group (safranin-O) 894 
at a) 6 months post op and b) 12 months post op. Fibrous-like repair tissue was observed at 6 895 
months becoming more hyaline-like with intensive safranin-O staining by 12 months. 896 
Scaffolds degraded at different rates. The multi-layered scaffold was almost completed 897 
degraded by 6 months (d), whereas the synthetic polymer scaffold remained largely intact (e). 898 
Remnants of synthetic polymer scaffold are shown at higher magnification (H&E staining) (f). 899 




Figure 8: Total histology scores for a) the trochlear ridge and b) the medial condyle 904 
demonstrated improved  tissue repair in the multi-layer scaffold group at 12 months post op. 905 
c) Cartilage thickness was quantified and found to be higher in the multi-layered scaffold 906 
group than in the empty defect and synthetic polymer scaffold groups at 6 and 12 months. 907 








  916 
Tables: 917 
 918 
Table 1: Study design showing the number of defects created in each group for osteochondral 919 




Empty group  
(n) 
Multi-layered 
scaffold group (n) 
Synthetic polymer 
scaffold group (n) 
 Defect site TR MC TR MC TR MC 
2 weeks - - 2 2 - - 
3 3 3 3 3 - - 
6 4 4 7 7 3 3 





Table 2: Gross morphology scoring system for cartilage repair. Maximum score possible score 926 
is 8 927 
 928 
Characteristic Grading Score 
Edge integration (new 
























Colour of cartilage, 
opacity or translucency 


















Table 3: Modified histological scoring system for cartilage repair. Maximum score possible is 940 
28 941 
 942 
Characteristic Grading Score 





Hyaline cartilage 4 
Mostly hyaline cartilage 3 
Mixed hyaline and fibrocartilage 2 
Mostly fibrocartilage 1 
Mostly fibrocartilage and non-chondrocytic 
cells 
0 
II. Structural Characteristics   
A. Surface regularity 
  
  
Smooth and intact 3 
Superficial horizontal lamination 2 
Fissures 1 
Severe disruption, including fibrillation 0 
B. Structural Integrity Normal 2 
  Slight disruption, including cysts 1 
Severe disintegration 0 
C. Thickness 
  
100% of normal adjacent cartilage 2 
50-100% of normal cartilage 1 
0-50% of normal cartilage 0 
D. Bonding to adjacent cartilage 
  
Bonded at both ends of graft 2 
Bonded at one end or partially at both ends 1 
Not bonded 0 
III. Freedom from cellular changes of degeneration  
A. Hypocellularity 
  
Normal cellularity 2 
Slight hypocellularity 1 
Moderate hypocellularity or hypercellularity 0 
B. Chondrocyte   clustering 
  
No clusters 2 
< 25% of the cells 1 
25-100% of the cells 0 
IV. Freedom from degradation changes in articular cartilage   
A. Freedom from degenerative 
changes in adjacent cartilage 
  
Normal cellularity, no clusters, normal 
staining 
3 
Normal cellularity, mild clusters, moderate 
staining 
2 
Mild or moderate hypocellularity, slight 
staining 
1 
Severe hypocellularity, poor or no staining 0 
V. Reconstitution of subchondral bone    
A. Reconstitution of subchondral bone 
Normal 3 
Reduced subchondral bone reconstitution 2 
Minimal subchondral bone reconstitution 1 
No subchondral bone reconstitution 0 
None/mild 2 
B. Inflammatory response in 
subchondral bone region 
Moderate 1 
Severe 0 
VI. Safranin-O staining Normal  3 
 Moderate  2 
 Slight  1 
 None  0 
Total maximum score  28 
 943 
 944 
